While one group reported increased growth in vivo in a melanoma cell line transfected with mutant IDH1 [30], another group reported a decrease in proliferation in glioma cell lines both in vitro and in vivo in the presence of mutant IDH1 [31]. This evidence concerns the gene IDH1 and central nervous system cancer.